Clinical Trials on Metastatic Breast Cancer in United States
Total 26620 results
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMetastatic Malignant Neoplasm in the Bone | Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7United States
-
Olema Pharmaceuticals, Inc.NovartisRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | HR-positive Breast Cancer | HER2-negative Breast CancerUnited States, Australia
-
Northwestern UniversityAmerican Cancer Society, Inc.CompletedMetastatic Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterTerminatedEndocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast CancerHormone-sensitive Metastatic Breast CancerUnited States
-
Imperial College LondonCancer Research UKCompletedMetastatic Breast Cancer | Locally Advanced Breast CancerUnited Kingdom
-
Georgetown UniversityTyme, IncTerminatedBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterCompletedBreast Cancer | Invasive Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast CarcinomaUnited States
-
Dana-Farber Cancer InstituteIncyte CorporationCompletedMetastatic Breast Cancer | Recurrent Breast CancerUnited States
-
Accelerated Community Oncology Research NetworkHoffmann-La Roche; AstraZenecaCompletedMetastatic Breast CancerUnited States
-
Duke UniversityRecruitingMetastatic Cancer | OligometastasisUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); AmgenTerminatedStage IV Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Breast Carcinoma Metastatic in the Bone | Circulating Tumor Cell CountUnited States
-
University of ArkansasOSI PharmaceuticalsTerminated
-
University of Colorado, DenverCancer League of ColoradoRecruiting
-
Massachusetts General HospitalCompletedCancer | Metastatic CancerUnited States
-
SCRI Development Innovations, LLCBristol-Myers Squibb; BayerCompletedMetastatic Breast CancerUnited States
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
Vascular Biogenics Ltd. operating as VBL TherapeuticsUnknownAdvanced and/or Metastatic Solid Organ CancerUnited States
-
Imperial College LondonMedical Research Council; ECMCRecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerUnited Kingdom
-
OncoMed Pharmaceuticals, Inc.CompletedMetastatic Breast CancerUnited States
-
SynDevRx, Inc.RecruitingMetastatic Breast Cancer | HR+/HER2-negative Breast CancerUnited States
-
Merrimack PharmaceuticalsCompletedMetastatic Breast Cancer | Her2 Amplified Solid TumorsUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingBreast Cancer | Metastatic Breast Cancer | Breast Cancer Stage IVUnited States
-
Verastem, Inc.TerminatedMetastatic Cancer | Non Hematologic CancersUnited States
-
Memorial Sloan Kettering Cancer CenterSynDevRx, Inc.RecruitingBreast Cancer | Metastatic Triple-Negative Breast CancerUnited States
-
Carrick Therapeutics LimitedBerlin-Chemie AG Menarini GroupRecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast CancerUnited States, Spain, France, United Kingdom
-
SCRI Development Innovations, LLCCelgeneCompletedMetastatic Breast CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Lymph Nodes | Metastatic Malignant Neoplasm in the Liver | Metastatic Breast Carcinoma | Metastatic Malignant Neoplasm in the Lung and other conditionsUnited States, Canada, Saudi Arabia, Korea, Republic of
-
University of WashingtonBreast Cancer Research FoundationNot yet recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast Carcinoma | Locally Advanced Unresectable HER2-Negative Breast Carcinoma | Locally Advanced Unresectable Hormone Receptor-Positive...United States
-
The Methodist Hospital Research InstituteMerck Sharp & Dohme LLCCompletedMetastatic Non-small Cell Lung Cancer | Metastatic Triple-negative Breast CancerUnited States
-
Cardiff UniversityWithdrawnMetastatic Breast CancerUnited Kingdom
-
Institute of Cancer Research, United KingdomTerminatedMetastatic Breast CancerUnited Kingdom
-
SCRI Development Innovations, LLCNovartisCompletedMetastatic Breast CancerUnited States
-
Angle plcCompletedHealthy Volunteers | Breast Cancer, MetastaticUnited States
-
University of Alabama at BirminghamTesaro, Inc.; Susan G. Komen Breast Cancer Foundation; Translational Breast Cancer... and other collaboratorsRecruitingMetastatic Breast Cancer | HER2 Positive Breast CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingStage IV Breast Cancer AJCC v6 and v7 | Metastatic Breast CarcinomaUnited States
-
University of California, San DiegoActive, not recruitingMetastatic CancerUnited States
-
Carrick Therapeutics LimitedPfizerRecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast CancerSpain, United States, Turkey, Hungary
-
EnhancedBio USA Inc.ZenopharmRecruitingMetastatic Breast Cancer | Locally Advanced Breast Cancer | HER2-Negative | Estrogen Receptor-PositiveUnited States, Korea, Republic of
-
AstraZenecaCompletedMetastatic Breast CancerItaly, United Kingdom, Brazil, Czechia, Poland, United States, Spain, Bulgaria, France
-
Merus N.V.CompletedBreast Cancer MetastaticUnited States, France, Belgium, Spain, United Kingdom, Netherlands, Portugal
-
Emory UniversityNational Cancer Institute (NCI); Pfizer; National Institutes of Health (NIH)CompletedAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Metastatic Breast CarcinomaUnited States
-
BioInvent International ABActive, not recruitingHER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | HER2-positive Metastatic Breast CancerSpain, United Kingdom, Germany
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedParenting | Metastatic Breast CancerUnited States
-
University of California, San FranciscoEisai Inc.CompletedMalignant Solid Tumour | Breast Cancer Nos Metastatic Recurrent | NeuropathyUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedBreast Cancer | Metastatic CancerUnited States
-
Indiana UniversityRecruitingMetastatic Cancer | Advanced CancerUnited States
-
Indiana UniversityIndiana University HealthCompletedFeasibility, Acceptability and Preliminary Effects of the Spiritual Care Assessment and InterventionMetastatic Cancer | Advanced CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)WithdrawnAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Breast Inflammatory CarcinomaUnited States